Evidence map›Paper›PMID 26663086›Full record

ArticleThe Journal of biological chemistry2016

Mitotic Activation of a Novel Histone Deacetylase 3-Linker Histone H1.3 Protein Complex by Protein Kinase CK2.

Hemangi Patil, Carrie Wilks, Rhiannon W Gonzalez, Sudheer Dhanireddy, Heather Conrad-Webb, Michael Bergel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Maintaining Transcriptional Specificity Through Mitosis.Annual review of genomics and human genetics · 2022
    Review
  3. Article
  4. Article
  5. Review
  6. The missing linkGenes & development · 2021
    Review
  7. Article
  8. Review
  9. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2018
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hemangi PatilFrom the Department of Biology, Texas Woman's University, Denton, Texas 76204.
Carrie WilksFrom the Department of Biology, Texas Woman's University, Denton, Texas 76204.
Rhiannon W GonzalezFrom the Department of Biology, Texas Woman's University, Denton, Texas 76204.
Sudheer DhanireddyFrom the Department of Biology, Texas Woman's University, Denton, Texas 76204.
Heather Conrad-WebbFrom the Department of Biology, Texas Woman's University, Denton, Texas 76204.
Michael BergelFrom the Department of Biology, Texas Woman's University, Denton, Texas 76204 MBergel@twu.edu.
Texas Woman's University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone deacetylase 3 (HDAC3) and linker histone H1 are involved in both chromatin compaction and the regulation of mitotic progression. However, the mechanisms by which HDAC3 and H1 regulate mitosis and the factors controlling HDAC3 and H1 activity during mitosis are unclear. Furthermore, as of now, no association between class I, II, or IV (non-sirtuin) HDACs and linker histones has been reported. Here we describe a novel HDAC3-H1.3 complex containing silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and nuclear receptor corepressor 1 (N-CoR) that accumulated in synchronized HeLa cells in late G2 phase and mitosis. Nonetheless, the deacetylation activity by HDAC3 in the complex was evident only in mitotic complexes. HDAC3 associated with H1.3 was highly phosphorylated on Ser-424 only during mitosis. Isolation of inactive HDAC3-H1.3 complexes from late G2 phase cells, and phosphorylation of HDAC3 in the complexes at serine 424 by protein kinase CK2 (also known as casein kinase 2) activated the HDAC3 in vitro. In vivo, CK2α and CK2α' double knockdown cells demonstrated a significant decrease in HDAC3 Ser-424 phosphorylation during mitosis. HDAC3 and H1.3 co-localized in between the chromosomes, with polar microtubules and spindle poles during metaphase through telophase, and partially co-localized with chromatin during prophase and interphase. H1 has been reported previously to associate with microtubules and, therefore, could potentially function in targeting HDAC3 to the microtubules. We suggest that phosphorylation of HDAC3 in the complex by CK2 during mitosis activates the complex for a dual role: compaction of the mitotic chromatin and regulation of polar microtubules dynamic instability.

Indexed as

MitosisProtein Processing, Post-TranslationalAcetylationCasein Kinase IIChromatinEnzyme ActivationG2 PhaseHeLa CellsHistone Deacetylase 3Histone DeacetylasesHistonesHumansMCF-7 CellsNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2PhosphorylationCasein Kinase IIChromatinCSNK2A1 protein, humanHistone Deacetylase 3Histone DeacetylasesHistonesNCOR1 protein, humanNCOR2 protein, humanNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2Protein IsoformsRecombinant ProteinsSerinechromatinhistone deacetylase 3 (HDAC3)linker histone H1.3mitosismitotic spindleprotein kinaseprotein kinase CK2

Identifiers

PMID26663086
PMCPMC4751364
OpenAlexW2193979452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.